Stock price performance of Cambrex Corporation is analyzed for various periods using several stock trading signals. In this case, The stock price has rallied 11.59% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 31.31% . Looking at the past 52 week period, the stock price is up at 87.18% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of Cambrex Corporation has a positive value of 22.61 compared to overall market. For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a 20-day Moving Average of 2.43% and the 50-Day Moving Average is 0.49%.The 200 Day SMA reached 9.09%
Cambrex Corporation is having a Relative Strength Index of 63.26 which indicates the stock is not yet over sold or over bought based on the technical indicators. Cambrex Corporation (NYSE:CBM) has climbed 9.29% in the past week and advanced 2.64% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 9.16% and the outperformance has advanced to 1.73% for the last 4 weeks period.
Company has reported several Insider transactions to the SEC, on Dec 15, 2016, Shawn Cavanagh (EVP & COO) sold 30,000 shares at 53.58 per share price.On Nov 15, 2016, Gregory Sargen (Executive Vice President & CFO) sold 22,500 shares at 52.02 per share price.On Nov 14, 2016, Steven M Klosk (President & CEO) sold 50,000 shares at 50.87 per share price.
Cambrex Corporation Last issued its quarterly earnings results on Feb 3, 2017. The company reported $1.23 EPS for the quarter, beating the analyst consensus estimate by $ 0.19. Analyst had a consensus of $1.04. The company had revenue of $178.70 million for the quarter, compared to analysts expectations of $174.53 million. The companys revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.01 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Company shares were Reiterated by First Analysis Sec on Jan 17, 2017 to Overweight, Raises Price Target to $ 66 from a previous price target of $54 .
Cambrex Corporation (NYSE:CBM) : On Friday heightened volatility was witnessed in Cambrex Corporation (NYSE:CBM) which led to swings in the share price. The stock opened for trading at $54.75 and hit $62.5 on the upside , eventually ending the session at $58.25, with a gain of 14.22% or 7.25 points. The heightened volatility saw the trading volume jump to 1,811,548 shares. The 52-week high of the share price is $62.5 and the company has a market cap of $1,873 million. The 52-week low of the share price is at $29.5 .
Cambrex Corporation manufactures and markets a broad line of specialty chemicals and commodity chemical intermediates and also manufactures chemicals to customer specifications. There are five product categories: pharmaceutical bulk actives; pharmaceutical intermediates; organic intermediates; performance enhancers; and polymer systems.